Amgen Inc (NASDAQ:AMGN)

285.50
Delayed Data
As of Dec 02
 -0.44 / -0.15%
Today’s Change
199.31
Today|||52-Week Range
296.67
+26.91%
Year-to-Date
FTX Collapse: Lessons for Investors
Dec 03 / MotleyFool.com - Paid Partner Content
Why Horizon Therapeutics Stock Is Skyrocketing Today
Nov 30 / MotleyFool.com - Paid Partner Content
Is Amgen Stock a Buy for Income Investors?
Dec 02 / MotleyFool.com - Paid Partner Content
The Most-Sold Guru Stocks of the 3rd Quarter
Nov 28 / GuruFocus News - Paid Partner Content
3 Stocks Every Investor Should Add to Their Watchlist This Week
Dec 02 / StockNews.com - Paid Partner Content
Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus
Nov 28 / Zacks.com - Paid Partner Content
Robeco Institutional Asset Management B.V. Buys 4, Sells 1 in 3rd Quarter
Dec 01 / GuruFocus News - Paid Partner Content
Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations
Nov 24 / Zacks.com - Paid Partner Content
Horizon (HZNP) Up on Initial Talks of Buyout by Pharma Giants
Nov 30 / Zacks.com - Paid Partner Content
Buy this Medical Sector Pioneer Stock
Nov 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close285.94
Today’s open282.89
Day’s range282.89 - 286.09
Volume139,454
Average volume (3 months)2,741,902
Market cap$152.3B
Data as of 4:00pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)-16.60%
Earnings growth (this year)+3.41%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+2.94%
P/E ratio22.9
Price/Sales4.96
Price/Book23.79

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+1.14+1.30%
----
MRNAModerna Inc+0.87+0.48%
BIIBBiogen-3.03-1.00%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateFebruary 2, 2023
EPS forecast (this quarter)$4.10
Annual revenue (last year)$26.0B
Annual profit (last year)$5.9B
Net profit margin22.68%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts